Aaron Bell

Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis

Michele D. Vos, Chad A. Ellis, Aaron Bell et al. · Journal of Biological Chemistry · 2000 · 295 citations · Full text

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

Samuel C. Mok, Tomás Bonome, Vinod Vathipadiekal et al. · Cancer Cell · 2009 · 255 citations · Full text

Survival Factor, Oncology, Microfibril-associated Glycoprotein 2 +9

Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas

Michael J. Birrer, Michael E. Johnson, Ke Hao et al. · Journal of Clinical Oncology · 2007 · 145 citations

Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Vidmantas Petraitis, Rūta Petraitienė, Andreas H. Groll et al. · Antimicrobial Agents and Chemotherapy · 1998 · 119 citations · Full text

Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Catherine H. Choi, Brian P. Schoenfeld, Aaron Bell et al. · Brain Research · 2010 · 106 citations · Full text

Synaptic Plasticity, Synaptic Plasticity Deficits, Neurophysiology +12